PatentsUSA
ViiV Healthcare Initiates Patent Infringement Lawsuits Against Gilead Sciences Over Bictegravir in US and Canada
ViiV Healthcare, majority-owned by GSK, has commenced patent infringement proceedings against Gilead Sciences Inc. in both the United States and Canada. The litigation concerns Gilead’s triple combination HIV drug containing bictegravir, which ViiV alleges infringes its patents covering dolutegravir and related chemic…
Monday, July 2, 2018